ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
UCB at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
UCB brings 6 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2401, 3201. Its program centres on axial spondyloarthritis and psoriatic arthritis, including a head-to-head trial, bimekizumab cost per responder and a digital management platform, with further work on lupus across pregnancy and how rheumatoid factors bind biologic drugs.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
UCB Brussels, Belgium | |
A biopharmaceutical company developing medicines for neurological and autoimmune conditions. | Booth Exhibiting at Booth 2401, 3201 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Industry Sun Nov 8 10:30am–11:15am A Bold Step Forward: BE BOLD — A Head-to-Head Superiority Trial in PsA Poster Sun Nov 8 10:30am–12:30pm Industry Sun Nov 8 5:30pm–7:30pm Making Waves in axSpA and HS Connecting Diseases Through Shared Immune Pathways Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 5:30pm–7:30pm Every Conversation Counts: Supporting Disease Control Across the SLE Reproductive Journey Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at UCB
Tell us what you sell and we’ll find the people at UCB most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction